Promega Pd-1Pd-L1 Cell

PD-1/PD-L1 Inhibitor 1
B1213-25 each
EUR 679.2

Human IgG antibody Laboratories manufactures the promega pd-1/pd-l1 cell reagents distributed by Genprice. The Promega Pd-1/Pd-L1 Cell reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Promega. Other Promega products are available in stock. Specificity: Promega Category: Pd-1/Pd-L1 Group: Cell

PD-1/PD-L1 Inhibitor 2
each
EUR 242.4

PD-1/PD-L1 inhibitor 2
25 mg
EUR 268
Description: Apoptosis|PD-1/PD-L1 interaction#Apoptosis

PD-1/PD-L1 inhibitor 2
5 mg
EUR 84
Description: Apoptosis|PD-1/PD-L1 interaction#Apoptosis

PD-1/PD-L1 Inhibitor 3
1 mg
EUR 248.8
Description: Apoptosis|PD-1/PD-L1 interaction

PD-1/PD-L1 Inhibitor 3
5 mg
EUR 837.6
Description: Apoptosis|PD-1/PD-L1 interaction

PD-1/PD-L1-IN-29
1 mg
EUR 919.93
Description: PD-1/PD-L1-IN-29 (S4-1) is a potent PD-1/PD-L1 inhibitor with an IC50 value of 6.1 nM. PD-1/PD-L1-IN-29 binds PD-L1 and disrupts PD-1/PD-L1 interactions, induces PD-L1 dimerization and internalization, improves its localization to the endoplasmic reticulum, and promotes PD-L1 entry into the endoplasmic reticulum. PD-1/PD-L1-IN-29 has anticancer activity[1].

PD-1/PD-L1-IN-31
Get quote Ask for price
Description: PD-1/PD-L1-IN-31 is a PD-1/PD-L1 inhibitor (IC50=2.2 nM). PD-1/PD-L1-IN-31 promotes secretion of the IFN-γ, and induces immune activity of peripheral blood mononuclear cells (PBMCs) to inhibits tumor cells[1].

Cell information

PROTAC PD-1/PD-L1 degrader-1
MBS5800413-5x10mg 5x10(mg
EUR 5795

PROTAC PD-1/PD-L1 degrader-1
T40112-10mg 10mg Ask for price
Description: PROTAC PD-1/PD-L1 degrader-1

PROTAC PD-1/PD-L1 degrader-1
T40112-1g 1g Ask for price
Description: PROTAC PD-1/PD-L1 degrader-1

PROTAC PD-1/PD-L1 degrader-1
T40112-1mg 1mg Ask for price
Description: PROTAC PD-1/PD-L1 degrader-1

PROTAC PD-1/PD-L1 degrader-1
T40112-50mg 50mg Ask for price
Description: PROTAC PD-1/PD-L1 degrader-1

PROTAC PD-1/PD-L1 degrader-1
T40112-5mg 5mg Ask for price
Description: PROTAC PD-1/PD-L1 degrader-1

Human PD-L1 COLO205 Cell Line
E24C00028 each
EUR 1225
Description: Human

PD-L1 - CHO Recombinant Cell Line
60543 2 vials
EUR 5205
Description: Recombinant CHO-K1 cells constitutively expressing human PD-L1 (Programmed Cell Death 1 Ligand 1, CD274, B7 homolog 1 (B7- H1), GenBank accession #NM_014143).

PD-1/PD-L1 Inhibitor 2
B1050-25 each
EUR 679.2

PD-1/PD-L1 Inhibitor 2
B1050-5 each
EUR 242.4

PD-1/PD-L1 inhibitor 2
B6023-25 25 mg
EUR 268
Description: Apoptosis|PD-1/PD-L1 interaction#Apoptosis

PD-1/PD-L1 inhibitor 2
B6023-5 5 mg
EUR 84
Description: Apoptosis|PD-1/PD-L1 interaction#Apoptosis

PD-1/PD-L1 Inhibitor 3
B6191-1 1 mg
EUR 248.8
Description: Apoptosis|PD-1/PD-L1 interaction

PD-1/PD-L1 Inhibitor 3
B6191-5 5 mg
EUR 837.6
Description: Apoptosis|PD-1/PD-L1 interaction

PD-1/PD-L1-IN-29
HY-152240 1 mg
EUR 919.93
Description: PD-1/PD-L1-IN-29 (S4-1) is a potent PD-1/PD-L1 inhibitor with an IC50 value of 6.1 nM. PD-1/PD-L1-IN-29 binds PD-L1 and disrupts PD-1/PD-L1 interactions, induces PD-L1 dimerization and internalization, improves its localization to the endoplasmic reticulum, and promotes PD-L1 entry into the endoplasmic reticulum. PD-1/PD-L1-IN-29 has anticancer activity[1].

PD-1/PD-L1-IN-31
HY-149356 Get quote Ask for price
Description: PD-1/PD-L1-IN-31 is a PD-1/PD-L1 inhibitor (IC50=2.2 nM). PD-1/PD-L1-IN-31 promotes secretion of the IFN-γ, and induces immune activity of peripheral blood mononuclear cells (PBMCs) to inhibits tumor cells[1].

PD-1/PD-L1-IN 3
HY-103048 Get quote Ask for price
Description: PD-1/PD-L1-IN 3, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions extracted from patent WO2014151634A1, compound No.1. PD-1/PD-L1-IN 3 interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5.60 nM and 7.04 nM, respectively. PD-1/PD-L1-IN 3 can be used for the research of various diseases, including cancer and infectious diseases[1].